These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23583328)

  • 1. The ventral portion of the CA1 region of the hippocampus and the prefrontal cortex as candidate regions for neuromodulation in schizophrenia.
    Ewing SG; Winter C
    Med Hypotheses; 2013 Jun; 80(6):827-32. PubMed ID: 23583328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-based therapies for the treatment of schizophrenia.
    Donegan JJ; Lodge DJ
    Brain Res; 2017 Jan; 1655():262-269. PubMed ID: 27544423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical disinhibition in the neonatal ventral hippocampal lesion model of schizophrenia: new vistas on possible therapeutic approaches.
    O'Donnell P
    Pharmacol Ther; 2012 Jan; 133(1):19-25. PubMed ID: 21839776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis.
    Jann MW
    Pharmacotherapy; 2004 Dec; 24(12):1759-83. PubMed ID: 15585443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the hippocampus on interneurons of the rat prefrontal cortex.
    Tierney PL; Dégenètais E; Thierry AM; Glowinski J; Gioanni Y
    Eur J Neurosci; 2004 Jul; 20(2):514-24. PubMed ID: 15233760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Storage, recall, and novelty detection of sequences by the hippocampus: elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine.
    Lisman JE; Otmakhova NA
    Hippocampus; 2001; 11(5):551-68. PubMed ID: 11732708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal CA1 deformity is related to symptom severity and antipsychotic dosage in schizophrenia.
    Zierhut KC; Graßmann R; Kaufmann J; Steiner J; Bogerts B; Schiltz K
    Brain; 2013 Mar; 136(Pt 3):804-14. PubMed ID: 23388407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia.
    Hadar R; Bikovski L; Soto-Montenegro ML; Schimke J; Maier P; Ewing S; Voget M; Wieske F; Götz T; Desco M; Hamani C; Pascau J; Weiner I; Winter C
    Mol Psychiatry; 2018 Apr; 23(4):943-951. PubMed ID: 28373685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory gating deficits, pattern completion, and disturbed fronto-limbic balance, a model for description of hallucinations and delusions in schizophrenia.
    Javanbakht A
    Med Hypotheses; 2006; 67(5):1173-84. PubMed ID: 16824690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The principal features and mechanisms of dopamine modulation in the prefrontal cortex.
    Seamans JK; Yang CR
    Prog Neurobiol; 2004 Sep; 74(1):1-58. PubMed ID: 15381316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-d-aspartate stimulation of the ventral hippocampus in rats.
    Peleg-Raibstein D; Pezze MA; Ferger B; Zhang WN; Murphy CA; Feldon J; Bast T
    Neuroscience; 2005; 132(1):219-32. PubMed ID: 15780480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine modulation of prefrontal cortex interneurons occurs independently of DARPP-32.
    Trantham-Davidson H; Kröner S; Seamans JK
    Cereb Cortex; 2008 Apr; 18(4):951-8. PubMed ID: 17693396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters.
    O'Donnell P; Grace AA
    Schizophr Bull; 1998; 24(2):267-83. PubMed ID: 9613625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis.
    Suzuki M; Zhou SY; Takahashi T; Hagino H; Kawasaki Y; Niu L; Matsui M; Seto H; Kurachi M
    Brain; 2005 Sep; 128(Pt 9):2109-22. PubMed ID: 15930048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased CaMKII and PKC activities in specific brain regions are associated with cognitive impairment in neonatal ventral hippocampus-lesioned rats.
    Yabuki Y; Nakagawasai O; Moriguchi S; Shioda N; Onogi H; Tan-No K; Tadano T; Fukunaga K
    Neuroscience; 2013 Mar; 234():103-15. PubMed ID: 23313709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational cognitive models of prefrontal-striatal-hippocampal interactions in Parkinson's disease and schizophrenia.
    Moustafa AA; Gluck MA
    Neural Netw; 2011 Aug; 24(6):575-91. PubMed ID: 21411277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine modulates temporal dynamics of feedforward inhibition in rat prefrontal cortex in vivo.
    Tierney PL; Thierry AM; Glowinski J; Deniau JM; Gioanni Y
    Cereb Cortex; 2008 Oct; 18(10):2251-62. PubMed ID: 18222936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep brain stimulation of the ventral hippocampus restores deficits in processing of auditory evoked potentials in a rodent developmental disruption model of schizophrenia.
    Ewing SG; Grace AA
    Schizophr Res; 2013 Feb; 143(2-3):377-83. PubMed ID: 23269227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat.
    Vertes RP
    Neuroscience; 2006 Sep; 142(1):1-20. PubMed ID: 16887277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.